Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 4, 2004, Pages 809-817

  Corona, Alberto ^a   Wilson, A Peter R ^b   Grassi, Mario ^c   Singer, Mervyn ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Antibiotic therapy; Fungaemia; Intensive care unit

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; FLUCLOXACILLIN; FLUCONAZOLE; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; CLINICAL OBSERVATION; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONTROL STRATEGY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; FUNGEMIA; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MONOTHERAPY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; OSTEOMYELITIS; OUTCOMES RESEARCH; PATIENT MONITORING; PATIENT REFERRAL; PATIENT SATISFACTION; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT INFECTION; SHORT COURSE THERAPY; TREATMENT PLANNING; UNIVERSITY HOSPITAL;

EID: 6344258819     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh416     Document Type: Article

References (41)

1. Pittet, D. (1997). Nosocomial bloodstream infections. In Prevention and Control of Nosocomial Infections, 3rd edn (Wenzel, R. P., Ed.), pp. 712-69. Williams & Wilkins, Baltimore, MD, USA.
2. Valles, J., Ochagavia, A., Rue, M. et al. & the Spanish Study Group of Infection Disease in ICU. (2000). Critically ill patients with community acquired bacteremia: characteristics and prognosis. Intensive Care Medicine 26, Suppl. 3, 21 (abstract).
3. Brun-Buisson, C., Doyon, F., Carlet, J. et al. (1985). Incidence, risk factors and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. Journal of the American Medical Association 274, 968-74.
4. Vincent, J. L., Bihari, D. J., Suter, P. M. et al. (1995). Prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. Journal of the American Medical Association 274, 639-44.
5. Brun-Buisson, C., Doyon, F. & Carlet, J. (1996). Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French bacteremia sepsis study group. American Journal of Respiratory and Critical Care Medicine 154, 617-24.
6. Rello, J., Ricart, M., Mirelis, B. et al. (1994). Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Medicine 20, 94-8.
7. Edgeworth, J. D., Treacher, D. F. & Eykyn, S. J. (1999). A 25-year study of nosocomial bacteremia in an adult intensive care unit. Critical Care Medicine 27, 1421-8.
8. Valles, J., Cristobal, L. & Alvarez-Lerma, F. (1997). Nosocomial bacteraemia in critically ill patients: a multicentre study evaluating epidemiology and prognosis. The Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clinical Infectious Diseases 24, 387-95.
9. Antonelli, M., Moro, M. L., D'Errico, R. R. et al. (1996). Early and late onset bacteremia have different risk factors in trauma patients. Intensive Care Medicine 22, 735-41.
10. Pittet, D., Tarara, D. & Wenzel, R. P. (1994). Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs and attributable mortality. Journal of the American Medical Association 271, 1598-601.
11. Pittet, D., Thievent, B., Wenzel, R. P. et al. (1996). Bedside prediction of mortality from bacteremic sepsis. American Journal of Respiratory and Critical Care Medicine 153, 684-93.
12. Friedman, G., Silva, E. & Vincent, J. L. (1998). Has the mortality of septic shock changed with time? Critical Care Medicine 26, 2078-86.
13. Ibrahim, E. H., Sherman, G., Ward, S. et al. (2000). The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118, 146-55.
14. Corona, A., Bertolini, G., Ricotta, A. M. et al. (2003). Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. Journal of Antimicrobial Chemotherapy 52, 849-52.
15. Weber, D. J., Raasch, R. & Rutala, W. A. (1999). Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest 115, Suppl. 3, 34S-41S.
16. Yates, R. R. (2000). New intervention strategies for reducing antibiotic resistance. Chest 115, Suppl. 3, 24S-27S.
17. CDC Update. (1997). Staphylococcus aureus with reduced susceptibility to vancomycin in United States. Morbidity and Mortality Weekly Report 46, 813-5.
18. McGowan, J. E. (2000). Strategies for study of the role of cycling on antimicrobial use and resistance. Infection Control and Hospital Epidemiology 21, Suppl. 1, S36-43.
19. Burgess, D. S. (1999). Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance. Chest 115, Suppl. 3, 19S-23S.
20. Mouton, J. W. (1999). Combination therapy as a tool to prevent emergence of bacterial resistance. Infection 27, Suppl. 2, S24-8.
21. Elliott, T. S. J. & Lambert, H. A. (1999). Antibacterial resistance in the intensive care unit: mechanism and management. British Medical Bulletin 55, 259-76.
22. Freeman, J. & McGowan, J. E., Jr (1981). Methodologic issues in hospital epidemiology. I. Rates, case-finding and interpretation. Review of Infectious Diseases 3, 658-67.
23. Pottinger, J. M., Herwaldt, L. A. & Perl, T. M. (1997). Basics of surveillance - an overview. Infection Control and Hospital Epidemiology 18, 513-27.
24. Bone, R. C., Balk, R. A., Cerra, F. B. et al. (1992). Definition for sepsis and organ failure and guidelines for use of innovative therapy in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest 101, 1644-55.
25. Stokes, E. J., Ridgeway, G. L. & Wren, M. W. D. (1993). Clinical Microbiology, 7th edn. E. Arnold, London, UK.
26. Garner, J. S., Jarvis, W. R., Emori, T. G. et al. (1988). CDC definitions for nosocomial infections. American Journal of Infection Control 16, 128-40.
27. Lundberg, J. S., Perl, T. M. & Wiblin, T. (1998). Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Critical Care Medicine 26, 1020-4.
28. Yuan, M., Aucken, H., Hall, L. et al. (1998). Epidemiological typing of klebsiellae with extended spectrum β-lactamases from European intensive care units. Journal of Antimicrobial Chemotherapy 41, 527-39.
29. Livermore, D. M. & Yuan, M. (1996). Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. Journal of Antimicrobial Chemotherapy 38, 409-24.
30. Pujol, M., Pena, C., Pallares, R. et al. (1996). Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. American Journal of Medicine 100, 509-16.
31. Perez-Gorricho, B. & Ripoll, M. (2003). Does short-course antibiotic therapy better meet patient expectations? International Journal of Antimicrobial Agents 21, 222-8.
32. Ribera, E., Gomez-Jimenez, J., Cortes, E. et al. (1996). Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Annals of Internal Medicine 125, 969-74.
33. Blot, S. I., Vandewoude, K. H., Hoste, E. A. et al. (2002). Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Archives of Internal Medicine 162, 2229-35.
34. Pfaller, M. A., Jones, R. N. & Doern, G. V. (1999). International surveillance of bloodstream infections due to Candida spp. in the European SENTRY program: species, distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagnostic Microbiology and Infectious Disease 35, 19-25.
35. Nolla-Salas, J., Sitges-Serra, A. & Leon-Gil, C. (1997). Candidaemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infections in the ICU. Intensive Care Medicine 23, 23-30.
36. Vincent, J. L., Anaissie, E. & Bruining, H. (1998). Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Medicine 24, 206-16.
37. Flanagan, P. G. & Barnes, R. A. (1998). Fungal infections in the intensive care unit. Journal of Hospital Infection 38, 163-77.
38. Weinstein, M. P., Towns, M. L. & Quartey, S. M. (1997). The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology and outcome of bacteremia and fungemia in adults. Clinical Infectious Diseases 24, 584-602.
39. Herwaldt, L. A., Geiss, M., Kao, C. et al. (1996). The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clinical Infectious Diseases 22, 14-20.
40. Roberts, F. J. (1989). Definition of polymicrobial bacteremia. Review of Infectious Diseases 11, 1029-30.
41. Weinstein, M. P. & Reller, L. B. (1984). Clinical importance of breakthrough bacteremia. American Journal of Medicine 76, 175-80.